Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Ovia Health Debuts Series of COVID-19 Vaccine Guides to Help Parents and Parents-to-be Make Informed Decisions About Their Health

Illustrated in-app guides provide guidance for every stage of the family-building journey


News provided by

Ovia Health

Jun 11, 2021, 09:00 ET

Share this article

Share toX

Share this article

Share toX


BOSTON, June 11, 2021 /PRNewswire-PRWeb/ -- Ovia Health, the only clinically-backed family health digital platform, has rolled out a dynamic new set of interactive guides to help families make critical decisions about the COVID-19 vaccines. The COVID Vaccine Informational Guides, appearing natively for users of Ovia's Fertility, Pregnancy, and Parenting apps, are available today in both English and Spanish.

The guides come at a key moment. Employers are charting paths back to safe in-person workplaces and tackling how to address vaccination policy, but vaccination progress and pace is waning. Although the United States has reached the milestone of 50% of people receiving at least one dose, rates of vaccination have slowed dramatically in the last two months, as supply of the vaccine has finally outpaced demand. Hesitancy to receive the COVID-19 vaccine is strongest among populations that are often at higher risk, such as people of color, those of lower socioeconomic status, and those with comorbidities.

Ovia, as a trusted, evidenced-based thought leader in reproductive health, has a unique opportunity to lead the field by providing clear, empathetic direction on COVID-19 vaccine guidelines in our community.

Post this

Another subpopulation expressing strikingly high vaccine hesitation rates are women trying to get pregnant, are already pregnant, or are newly postpartum--the same population that makes up much of the Ovia Health community. The adverse effects caused by COVID-19 on pregnant people and babies are well-known: increased risk of preterm birth, respiratory distress, and hospitalization. Data from Ovia users in December 2020 showed that almost half of users said they wouldn't take the vaccine. Despite more research and guidance released in the new year, an additional poll by Ovia Health in March 2021 suggested that 1 in 3 women are still hesitant to receive the vaccine. This anxiety is fueled by confusing guidance for pregnant or postpartum parents, misinformation about the vaccine's safety, and community stigma surrounding the COVID-19 vaccine.

Through a 5-10 minute module, the guides provide awareness and latest vaccine guidance for decision support in a relatable conversational format between a fictional Ovia member and her certified nurse midwife. They discuss frequently asked questions surrounding the COVID-19 vaccine's impact on reproductive health, such as:
The initial clinical trials didn't include pregnant or breastfeeding women. How do I know the vaccine is safe for me?
I'm unsure of the vaccine development process. How do I really know if they work?
Is it safe to get the vaccine if I have allergies?
Will the vaccine negatively impact my fertility or my baby's development?
What are the current recommendations for women trying to conceive regarding the COVID-19 vaccine?
What are the current recommendations for pregnant women regarding the COVID-19 vaccine?
What are the current recommendations for my children regarding the COVID-19 vaccine?

The COVID Vaccine Informational Guides, like all of Ovia's content, are rooted in clinical evidence from governing bodies like ACOG (American College of Obstetricians and Gynecologists), ACNM (American College of Certified-Nurse Midwives), and ASRM (American Society for Reproductive Medicine). The guide is updated on a weekly basis to ensure Ovia is sharing the most up-to-date vaccine-related evidence with its community, especially as clinical trials with pregnant women and children are ongoing.

Most importantly, the guide brings the recommendations to life by breaking down daunting questions into clear explanations, and provides a talk track for members to ask these same questions to their own doctors, midwives, pediatricians, and other providers.

"Ovia, as a trusted, evidenced-based thought leader in reproductive health, has a unique opportunity to lead the field by providing clear, empathetic direction on COVID-19 vaccine guidelines in our community. Our members turn to us to help them navigate some of the most complex decisions about fertility, pregnancy, and parenting," said Paris Wallace, Ovia Health Chief Executive Officer. "Now, we're ready to help our members sift through misinformation and provide clear and concise educational resources to help make important decisions for them and their families. "

The guide presents evidenced-based information about the COVID-19 vaccine through empathetic storytelling, and does not encourage or endorse vaccination. To download the Ovia apps for free and see the guides in action, click here. For more clinical perspectives on vaccine decisions for women and families, click here: https://info.oviahealth.com/ent-covid-vaccine.

About Ovia Health
Since 2012, Ovia Health has helped more than 15 million people successfully navigate their parenthood journeys and is on a mission to make a happy, healthy family possible for everyone. Ovia is the only family health solution clinically proven to effectively identify and intervene with high-risk conditions. The company's 50+ clinical programs, including predictive coaching and personalized care plans, help prevent unnecessary healthcare costs, improve health outcomes, and foster a family-friendly workplace that increases retention and return-to-work. For more information, visit OviaHealth.com.

Media Contact:
Shannon Mullins
Scratch Marketing + Media for Ovia Health
[email protected]

Media Contact

Shannon Mullins, Scratch Marketing + Media, +1 2039233143, [email protected]

SOURCE Ovia Health

Related Links

https://www.oviahealth.com/

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.